김민석 (DGIST)님 | 한빛사연구자 > 한빛사

DGIST

CV File

바이오센싱 및 나노바이오물질

최종업데이트 2023.02.27.

Silver electroceutical technology to treat sarcopenia
- Proc. Natl. Acad. Sci. USA, 2023 Aug 15;120(33):e2300036120 | https://doi.org/10.1073/pnas.2300036120
- 2023-08
- 바이오·의료융합
- 한빛사논문
Cytokine engineered NK-92 therapy to improve persistence and anti-tumor activity
- Theranostics, 2023 Mar 5;13(5):1506-1519 | doi: 10.7150/thno.79942
- 2023-03
- 바이오·의료융합
- 한빛사논문
Lossless Immunocytochemistry Based on Large-Scale Porous Hydrogel Pellicle for Accurate Rare Cell Analysis
- ACS Appl. Mater. Interfaces, Publication Date:February 21, 2023 | https://doi.org/10.1021/acsami.2c18321
- 2023-02
- 바이오·의료융합
- 한빛사논문
Electroceutical approach ameliorates intracellular PMP22 aggregation and promotes pro-myelinating pathways in a CMT1A in vitro model
- Biosens. Bioelectron., Available online 30 December 2022 | https://doi.org/10.1016/j.bios.2022.115055
- 2022-12
- 바이오·의료융합
- 한빛사논문
Implantable Electroceutical Approach Improves Myelination by Restoring Membrane Integrity in a Mouse Model of Peripheral Demyelinating Neuropathy
- Adv. Sci., First published: 17 August 2022 | https://doi.org/10.1002/advs.202201358
- 2022-08
- 바이오·의료융합
- 한빛사논문
Continuous centrifugal microfluidics (CCM) isolates heterogeneous circulating tumor cells via full automation
- Theranostics, Published 2022-5-1, 12(8):3676-3689 | doi:10.7150/thno.72511
- 2022-05
- 바이오·의료융합
- 한빛사논문
An electroceutical approach enhances myelination via upregulation of lipid biosynthesis in the dorsal root ganglion
- Biofabrication, Published 6 January 2022 | https://doi.org/10.1088/1758-5090/ac457c
- 2022-01
- 바이오·의료융합
- 한빛사논문
A microfluidic platform for 3-dimensional cell culture and cell-based assays
- Biomed. Microdevices, February 2007, Volume 9, Issue 1, pp 25-34 | 10.1007/s10544-006-9016-4
- 2007-02
- 바이오·의료융합
- 상위피인용논문

연구자 ID

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기